Generative AI for drug discovery
Variational AI has raised $5.5M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Variational AI's investors include Flying Fish Partners, Merck Global Health Innovation Fund, Lip-Bu Tan, Amarjit Gill, Nimbus Synergies Inc..
Variational AI is headquartered in Vancouver, Canada.
Generative AI for drug discovery
Variational AI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Variational AI — Funding & Investors." VCBacked, February 20, 2025, https://www.vcbacked.co/company/variational-ai. Accessed September 14, 2026.
VCBacked. (2025). Variational AI — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/variational-ai
{{cite web |title=Variational AI — Funding & Investors |url=https://www.vcbacked.co/company/variational-ai |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated